#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Dementia Alzheimer's type Colorectal cancer Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Pyruvate kinase deficiency anaemia Splenic marginal zone lymphoma Leiomyosarcoma recurrent Progressive familial intrahepatic cholestasis Systemic sclerosis pulmonary Retinoblastoma Porphyria non-acute Glomerulonephritis minimal lesion Malignant melanoma Cholangiocarcinoma Obliterative bronchiolitis Paget's disease of the vulva Bone marrow disorder Immunodeficiency Marginal zone lymphoma refractory More trials…

    Learn about Rare Diseases

    Myxofibrosarcoma – Life with Disease Nodal marginal zone B-cell lymphoma – Life with Disease Rhabdomyosarcoma – Life with Disease Noonan syndrome – Basic Information Ocular melanoma – Trials in Disease Gaucher’s disease type I – Basic Information Factor VIII deficiency – Treatment Toxic epidermal necrolysis – Diagnostics Testicular leiomyosarcoma – Treatment Mucopolysaccharidosis II – Treatment More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Bcmacp03 Ecopipam Hydrochloride CARBOMER 980 Ataluren Rbp030.2 Corline Heparin Conjugate Ergocalciferol Bp FERUMOXTRAN-10 Omp11 Ziftomenib Gozetotide Nomegestrol Acetate Cefotaxime Sodium AAV9-CTNT-COBAG3 L-ALANINE Zasocitinib Islatravir GSKVX000000030810 Sulodexide Thiopental Sodium More therapies…

    Learn about Your Condition

    Malabsorption Skin cancer Delayed graft function Bladder cancer stage III Choroid melanoma Hepatic encephalopathy Glanzmann's disease Takayasu's arteritis Breast cancer female B-cell type acute leukaemia Anal cancer metastatic Dermatitis atopic Papilloma viral infection Tumour of ampulla of Vater Endometrial cancer More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Chronic rhinosinusitis with nasal polyps

  • Study on Stopping Mepolizumab or Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps After 12 Months Symptom-Free

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    • Mepolizumab
    Denmark

  • Study on the Effects of SAR443765 and Mometasone Furoate in Adults with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    2 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • LUNSEKIMIG
    • Mometasone Furoate
    Belgium Bulgaria Poland

  • Study on Benralizumab and Mometasone Furoate for Patients with Severe Eosinophilic Chronic Rhinosinusitis with Nasal Polyps and Asthma

    Not recruiting

    3 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Mometasone Furoate
    • Benralizumab
    Belgium Bulgaria Hungary Italy Poland

  • Study on the Effects of Verekitug (UPB-101) for Patients with Chronic Rhinosinusitis with Nasal Polyps Using Nasal Corticosteroids

    Not recruiting

    2 1
    Investigated Diseases:
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Human Igg1 Kappa Monoclonal Antibody Against Crlf2
    Czechia Germany Poland Spain

  • Study on the Effect of Dupilumab for Patients with Chronic Rhinosinusitis with Nasal Polyps

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    • Chronic rhinosinusitis without nasal polyps
    • Chronic rhinosinusitis with nasal polyps
    Investigated Drugs:
    • Dupilumab
    Austria

  • Study Comparing Dupilumab and Mepolizumab for Treating Chronic Rhinosinusitis with Nasal Polyps in Danish Patients

    Not recruiting

    3 1 1 1
    Investigated Drugs:
    • Dupilumab
    • Mepolizumab
    • Mometasone Furoate
    Denmark
Previous Page
1 2 3 4
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!